Related Articles
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
L858R-positive lung adenocarcinoma with KRAS G12V, EGFR T790M and EGFR L858R mutations: A case report
Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay
Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC
Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors